IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v13y2022i1d10.1038_s41467-022-33832-6.html
   My bibliography  Save this article

Nebulized fusion inhibitory peptide protects cynomolgus macaques from measles virus infection

Author

Listed:
  • Olivier Reynard

    (INSERM U1111, CNRS, UMR5308, Univ Lyon, Université Claude Bernard Lyon 1, École Normale Supérieure de Lyon)

  • Claudia Gonzalez

    (INSERM U1111, CNRS, UMR5308, Univ Lyon, Université Claude Bernard Lyon 1, École Normale Supérieure de Lyon)

  • Claire Dumont

    (INSERM U1111, CNRS, UMR5308, Univ Lyon, Université Claude Bernard Lyon 1, École Normale Supérieure de Lyon)

  • Mathieu Iampietro

    (INSERM U1111, CNRS, UMR5308, Univ Lyon, Université Claude Bernard Lyon 1, École Normale Supérieure de Lyon)

  • Marion Ferren

    (INSERM U1111, CNRS, UMR5308, Univ Lyon, Université Claude Bernard Lyon 1, École Normale Supérieure de Lyon)

  • Sandrine Guellec

    (Université de Tours)

  • Lajoie Laurie

    (Université de Tours, Institut national de recherche pour l’agriculture, l’alimentation et l’environnement (INRAe), UMR1282, Infectiologie et santé publique (ISP))

  • Cyrille Mathieu

    (INSERM U1111, CNRS, UMR5308, Univ Lyon, Université Claude Bernard Lyon 1, École Normale Supérieure de Lyon)

  • Gabrielle Carpentier

    (PST-A, Université de Tours)

  • Georges Roseau

    (PST-A, Université de Tours)

  • Francesca T. Bovier

    (Columbia University Vagelos College of Physicians and Surgeons)

  • Yun Zhu

    (Columbia University Vagelos College of Physicians and Surgeons
    Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health)

  • Deborah Pennec

    (CEPR U1100, Université de Tours)

  • Jérome Montharu

    (PST-A, Université de Tours)

  • Amin Addetia

    (University of Washington Medical Center)

  • Alexander L. Greninger

    (University of Washington Medical Center)

  • Christopher A. Alabi

    (Cornell University)

  • Elise Brisebard

    (UMR703, PAnTher APEX, INRAE/Oniris)

  • Anne Moscona

    (Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians & Surgeons
    Columbia University Vagelos College of Physicians & Surgeons)

  • Laurent Vecellio

    (PST-A, Université de Tours)

  • Matteo Porotto

    (Columbia University Vagelos College of Physicians and Surgeons
    University of Studies of Campania ‘Luigi Vanvitelli’)

  • Branka Horvat

    (INSERM U1111, CNRS, UMR5308, Univ Lyon, Université Claude Bernard Lyon 1, École Normale Supérieure de Lyon)

Abstract

Measles is the most contagious airborne viral infection and the leading cause of child death among vaccine-preventable diseases. We show here that aerosolized lipopeptide fusion inhibitor, derived from heptad-repeat regions of the measles virus (MeV) fusion protein, blocks respiratory MeV infection in a non-human primate model, the cynomolgus macaque. We use a custom-designed mesh nebulizer to ensure efficient aerosol delivery of peptide to the respiratory tract and demonstrate the absence of adverse effects and lung pathology in macaques. The nebulized peptide efficiently prevents MeV infection, resulting in the complete absence of MeV RNA, MeV-infected cells, and MeV-specific humoral responses in treated animals. This strategy provides an additional means to fight against respiratory infection in non-vaccinated people, that can be readily translated to human trials. It presents a proof-of-concept for the aerosol delivery of fusion inhibitory peptides to protect against measles and other airborne viruses, including SARS-CoV-2, in case of high-risk exposure.

Suggested Citation

  • Olivier Reynard & Claudia Gonzalez & Claire Dumont & Mathieu Iampietro & Marion Ferren & Sandrine Guellec & Lajoie Laurie & Cyrille Mathieu & Gabrielle Carpentier & Georges Roseau & Francesca T. Bovie, 2022. "Nebulized fusion inhibitory peptide protects cynomolgus macaques from measles virus infection," Nature Communications, Nature, vol. 13(1), pages 1-16, December.
  • Handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-33832-6
    DOI: 10.1038/s41467-022-33832-6
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-022-33832-6
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/s41467-022-33832-6?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Leslie Roberts, 2020. "Why measles deaths are surging — and coronavirus could make it worse," Nature, Nature, vol. 580(7804), pages 446-447, April.
    2. Hironobu Tatsuo & Nobuyuki Ono & Kotaro Tanaka & Yusuke Yanagi, 2000. "SLAM (CDw150) is a cellular receptor for measles virus," Nature, Nature, vol. 406(6798), pages 893-897, August.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Caroline Chuard & Hannes Schwandt & Alexander D. Becker & Masahiko Haraguchi, 2022. "Economic vs. Epidemiological Approaches to Measuring the Human Capital Impacts of Infectious Disease Elimination," NBER Working Papers 30202, National Bureau of Economic Research, Inc.
    2. Koich Saeki & Akira Sasaki, 2018. "The role of spatial heterogeneity in the evolution of local and global infections of viruses," PLOS Computational Biology, Public Library of Science, vol. 14(1), pages 1-20, January.
    3. Yan Wang, 2022. "Does Governance Quality Matter for the Selection of Policy Stringency to Fight COVID-19?," IJERPH, MDPI, vol. 19(11), pages 1-14, May.
    4. Zohra S. Lassi & Rabia Naseem & Rehana A. Salam & Faareha Siddiqui & Jai K. Das, 2021. "The Impact of the COVID-19 Pandemic on Immunization Campaigns and Programs: A Systematic Review," IJERPH, MDPI, vol. 18(3), pages 1-23, January.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-33832-6. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.